Company: MYSEW
Filing Date: 2025-01-08
Form Type: 424B5
Source: 0001213900-25-002125
Chunk: 19

Company: Myseum, Inc.
Filing Date: 2025-01-08
Form: 424B5
Chunk 19
---
 the securities we are offering pursuant to this prospectus supplement and accompanying prospectus to one or more institutional or accredited investors through securities purchase agreements directly between the purchasers and us. We will only sell to such investors who have entered into the securities purchase agreement with us.

We expect to deliver the securities being offered pursuant to this prospectus supplement and accompanying prospectus on or about January 10, 2025, subject to satisfaction of customary closing conditions.

Pursuant to the terms of the securities purchase agreement and subject to certain exceptions, we are prohibited from entering into any agreement to issue or announcing the issuance or proposed issuance of any shares of Common Stock or securities convertible or exercisable into Common Stock for a period commencing on the date of this prospectus supplement and expiring 30 days from the closing date of this offering. Furthermore, we are also prohibited from entering into any agreement to issue Common Stock or Common Stock Equivalent (as defined in the securities purchase agreement) involving a Variable Rate Transaction (as defined in the securities purchase agreement), subject to certain exceptions, for a period commencing onthe date of this prospectus supplement and expiring six-months from the closing date of this offering.

Each of our executive officers
and directors have agreed, subject to certain exceptions, not to dispose of or hedge any shares of Common Stock or securities convertible
into or exchangeable for shares of Common Stock during the period from the date of the lock-up agreement continuing through the 30 days
after the closing of this offering.

We have agreed to pay the Placement Agent a total cash fee equal to 7.0% of the gross proceeds of this offering. We will also pay the Placement Agent in connection with this offering a non-accountable expense allowance equal to 1.0% of the gross proceeds raised in the offering, and $80,000 for expenses of legal counsel and other out-of-pocket expenses. We estimate that the total expenses of the offering payable by us, excluding the placement agent’s fees and the reimbursement noted above, will be approximately $75,000.

Placement Agent Warrants

In addition, we have agreed to
issue to the Placement Agent, or its designees, Placement Agent Warrants to purchase up to 60,000 shares of Common Stock, which represents
5.0% of the aggregate number of shares purchased in this offering at an exercise price of $4.25 per share (representing 100% of the public
offering price for a share of common stock to be sold in this offering). The Placement